Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
Health Catalyst (HCAT) Stock Price & Analysis
419 Followers
HCAT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.45 - $14.37
Previous Close$6.73
Volume468.77K
Average Volume (3M)652.69K
Market Cap
$397.31M
Enterprise Value$328.65M
Total Cash (Recent Filing)$317.73M
Total Debt (Recent Filing)$249.07M
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Aug 01, 2024EPS Estimate
$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.85
Shares Outstanding59,034,936
10 Day Avg. Volume512,123
30 Day Avg. Volume652,687
Standard Deviation0.15
R-Squared0.22
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)3.86
Price to Sales (P/S)1.34
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.22
Enterprise Value/Gross Profit2.49
Enterprise Value/Ebitda-3.61
Forecast
1Y Price Target
$10.71Price Target Upside59.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Health Catalyst News
PremiumCompany Announcements
Health Catalyst Executive Team Undergoes Major ReshuffleBulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted EBITDA exceeded consensus by 16% and demonstrated the company's ability to deliver financial results that surpass market expectations.
Operational EfficiencyThe shift to a cloud-native environment should improve HCAT's sales pipeline, conversion, and client growth, enhancing overall operational efficiency.
Product DevelopmentThe introduction of the new Ignite platform could lead to growth acceleration and improved margins in the long term.
Bears Say
Bankruptcy ProceedingsA client undergoing bankruptcy proceedings may contribute to short-term overhang for the stock.
Earnings MissRevenue slightly missed both analyst and consensus estimates, and adjusted EBITDA missed the analyst's estimate by 5%.
Growth Outlook2024 revenue guidance calls for just +4% year-over-year growth, which is below the previous expectations.
---
Ownership Overview
21.59% Insiders
27.32% Mutual Funds
39.25% Other Institutional Investors
11.83% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $5.45 and its highest was $14.37 in the past 12 months.
What is Health Catalyst’s market cap?
Currently, no data Available
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Aug 01, 2024 which is in 66 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on May 09, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.031 by $0.019.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is $0.08.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 59,034,935 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.05 in its last earnings report, beating expectations of $0.031. Following the earnings report the stock price went down -3.898%.
Which hedge fund is a major shareholder of Health Catalyst?
Among the largest hedge funds holding Health Catalyst’s share is PRIMECAP Management Co. It holds Health Catalyst’s shares valued at 16M.
---
Health Catalyst Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.71 (59.14% Upside)
$10.71 (59.14% Upside)
Blogger Sentiment
Neutral
HCAT Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 707.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $204.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.2%
Last 30 Days ▼ 8.4%
Last 30 Days ▼ 8.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.09%
12-Months-Change
Fundamentals
Return on Equity
-27.69%
Trailing 12-Months
Asset Growth
-7.60%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
---
HCAT Earnings Call
Q1 2024
0:00 / 0:00
---
HCAT Stock 12 Month Forecast
Average Price Target
$10.71
▲(59.14% Upside)
Technical Analysis
Best Analysts Covering HCAT
1 Year
1 Year Success Rate
4/16 ratings generated profit
1 Year Average Return
-15.07%
reiterated a buy rating 7 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -15.07% per trade.
---